Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

50.37
+1.002.03%
Post-market: 50.900.5300+1.05%19:59 EDT
Volume:35.99M
Turnover:1.81B
Market Cap:73.00B
PE:20.41
High:50.90
Open:49.22
Low:49.01
Close:49.37
52wk High:109.50
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:2.16
T/O Rate:2.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.93
PE(LYR):25.96

Loading ...

Should Boston Scientific’s Shift Toward Capital Spending and External Innovation Require Action From (BSX) Investors?

Simply Wall St.
·
2 hours ago

Movement Alert|Boston Scientific Rises 3.01% in Regular Trading, Two New Products Approved in China Boosting Market Sentiment

Market Focus
·
Yesterday

Boston Scientific (BSX) Rebounds Sharply, Is The Stock Still A Bargain?

Simply Wall St.
·
Aug 21

Boston Scientific Corp. Stock Slides 5.1%, Underperforms Peers

Dow Jones
·
Aug 21

Movement Alert|Boston Scientific Falls 3.04% in Regular Trading, Guidance Cut and Analyst Downgrades Continue to Weigh on Shares

Market Focus
·
Aug 20

Movement Alert|Boston Scientific Rises 3.21% in Regular Trading, New-Gen Prostate Treatment Device Rezum EVO Approved in China

Market Focus
·
Aug 19

Boston Scientific Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 19

Lone Pine Capital Llc Reports Share Stake of 2.6 Million Shares in Home Depot

Reuters
·
Aug 15

Lone Pine Capital Llc Raises Share Stake in Nu Holdings by 24.2% to 47.2 Mln Class a Shares - SEC Filing

THOMSON REUTERS
·
Aug 15

Lone Pine Capital Llc Dissolves Share Stake in Boston Scientific - SEC Filing

THOMSON REUTERS
·
Aug 15

Movement Alert|Boston Scientific Pre-Market Rise 3.85%, Earnings Beat and Restructuring Plan Continue to Drive Recovery

Market Focus
·
Aug 14

Movement Alert|Boston Scientific Rises 3.29% Overnight, Q2 Earnings Beat and Restructuring Plan Sustain Recovery Momentum

Market Focus
·
Aug 14

Citi Keeps Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Aug 13

Boston Scientific’s MANDARIN Trial Shines Spotlight on Liver Cancer Strategy in China

TIPRANKS
·
Aug 13

Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Aug 11

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Movement Alert|Boston Scientific Rises 3.01% in Regular Trading, Sector Strength and Post-Earnings Recovery Drive Gains

Market Focus
·
Aug 11

Resmed Inc Stock (RMD) Moved Up by 3.01% on Aug 10: Key Drivers Unveiled

TradingKey
·
Aug 10

Boston Scientific Publishes Update to Financial Calendar

Reuters
·
Aug 10

Boston Scientific, Circle, Illumina, Southern Co, Toyota Insider Frenzy

TIPRANKS
·
Aug 08